Anaesthesia for a morbidly obese patient with schizophrenia and intellectual disability

References

• Citrome L, Vreeland B. Schizophrenia, obesity, and antipsychotic medications: what can we do? Postgrad Med 2008; 120: 18–33.
   PubMed Web of Science ®Google Scholar
• Saarni SE, Saarni SI, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, Lönnqvist J. Body composition in psychotic disorders: a general population survey. Psychol Med 2008; 20: 1–10.
   Google Scholar
• Boke O, Aker S, Sarisoy G, Saricicek EB, Sahin AR. Prevalence of metabolic syndrome among inpatients with schizophrenia. Int J Psychiatry Med 2008; 38: 103–12.
   PubMed Web of Science ®Google Scholar
• Limosin F, Gasquet I, Leguay D, Azorin JM, Rouillon F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatr Scand 2008; 118: 19–25.
   PubMed Web of Science ®Google Scholar
• Morgan VA, Leonard H, Bourke J, Jablensky A. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. Br J Psychiatry 2008; 193: 364–72.
   PubMed Web of Science ®Google Scholar
• Greenwood CM, Husted J, Bomba MD, Hodgkinson KA, Bassett AS. Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res 2004; 48: 531–9.
   PubMed Web of Science ®Google Scholar
• Hudcova J, Schumann R. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient. Gen Hosp Psychiatry 2006; 28: 440–2.
   PubMed Web of Science ®Google Scholar
• Straus SM, Bleumink GS, Dieleman JP, van der Lei J. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164: 1293–7.
   PubMed Web of Science ®Google Scholar
• Kudoh A, Kimura F, Murakawa T, Ishihara H, Matsuki A. Perioperative management of patients on long-term administration of psychotropic drugs (in Japanese with English Abstract). Masui (Jpn J Anesthesiol) 1993; 42: 1056–64.
   PubMedGoogle Scholar
• Vohra SB. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Can J Anaesth 1994; 41: 420–2.
   PubMed Web of Science ®Google Scholar
• Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, Labarthe D, Seidell JC, Smith SC Jr; American Heart Association. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Circulation 2004; 110: e476–83.
   Google Scholar
• Singer P, Askanazi J. Morbid obesity and other nutritional disorders. In: Katz J, Benumof JL, Kadis LB (Ed.). Anesthesia and uncommon diseases, 3rd ed. Philadelphia: W. B. Saunders Company; 1990: 495–511.
   Google Scholar
• Tait AR, Voepel-Lewis T, Burke C, Kostrzewa A, Lewis I. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology 2008; 108: 375–80.
   PubMed Web of Science ®Google Scholar
• Wender R, Goldman AJ. Awake insertion of the fibreoptic intubating LMA CTrach in three morbidly obese patients with potentially difficult airways. Anaesthesia 2007; 62: 948–51.
   PubMed Web of Science ®Google Scholar
• Kira S, Koga H, Yamamoto S, Takeshima N, Hasegawa A, Miyakawa H, Noguchi T. Anesthetic management of laparoscopic adjustable gastric banding in Japanese patients with morbid obesity. J Anesth 2007; 21: 424–8.
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Minville V, Delanoue K, Mazerolles M, Concina D, Fourcade O. The importance of increased neck circumference to intubation difficulties in obese patients. Anesth Analg 2008; 106: 1132–6.
   PubMed Web of Science ®Google Scholar
• Fujinaga A, Fukushima Y, Kojima A, Sai Y, Ohashi Y, Kuzukawa A, Seto T, Nosaka S. Anesthetic management of an extremely obese patient. J Anesth 2007; 21: 261–4.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Hoshino T, Suzuki H, Kimura M, Ogawa R. Repeated propofol anesthesia for a patient with a history of neuroleptic malignant syndrome. Nippon Ika Daigaku Zasshi 1999; 66: 262–5.
   PubMedGoogle Scholar
• Richa FC, Yazbeck PH. Anaesthetic management of a child with Freeman-sheldon syndrome undergoing spinal surgery. Anaesth Intensive Care 2008; 36: 249–53.
   PubMed Web of Science ®Google Scholar
• La Colla L, La Colla G, Albertin A, Poli D, Baruffaldi Preis FW, Mangano A. The use of propofol and remifentanil for the anaesthetic management of a super-obese patient. Anaesthesia 2007; 62: 842–5.
   PubMed Web of Science ®Google Scholar
• Alvarez AO, Cascardo A, Albarracin Menendez S, Capria JJ, Cordero RA. Total intravenous anesthesia with midazolam, remifentanil, propofol and cistracurium in morbid obesity. Obes Surg 2000; 10: 353–60.
   PubMed Web of Science ®Google Scholar
• Schüttler J, Albrecht S, Breivik H, Osnes S, Prys-Roberts C, Holder K, Chauvin M, Viby-Mogensen J, Mogensen T, Gustafson I, Lof L, Noronha D, Kirkham AJ. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997; 52: 307–17.
   PubMed Web of Science ®Google Scholar
• Steinlechner B, Dworschak M, Birkenberg B, Lang T, Schiferer A, Moritz A, Mora B, Rajek A. Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose-finding study. Br J Anaesth 2007; 98: 598–603.
   PubMed Web of Science ®Google Scholar
• Castellani S, Ziegler MG, van Kammen DP, Alexander PE, Siris SG, Lake CR. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia. Arch Gen Psychiatry 1982; 39: 1145–9.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nakano M, Sano K, Kanri T. The effects of epinephrine in local anesthetics on plasma catecholamine and hemodynamic responses. Odontology 2005; 93: 72–9.
   PubMedGoogle Scholar